HROW NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Harrow Health Inc · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data Download investor PDF
Latest close 38.45 USD
-17.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -5.9% below the Trend Line and sits at 37.7% of its 52-week range. The latest completed week returned -17.6%, after a -8.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 37/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 31 out of 100
Latest Close 38.45 USD 24 Jul 2026
1W Return -17.6% latest completed week
4W Return -8.6% short-term follow-through
12W Return -6.0% quarterly tape
Trend Breadth 61.5% 32 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -17.6% Latest completed week; four-week move -8.6%. Indicator stack 34/77 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 37/100 conviction; expected move 17.6%. News sentiment 57/100 52 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -5.9% below the Trend Line and sits at 37.7% of its 52-week range. The latest completed week returned -17.6%, after a -8.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2112-week average 0.12

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.21Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.6% over four weeks, -6.0% over 12 weeks, and 6.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-17.6%
4W-8.6%
12W-6.0%
26W-13.5%
52W6.2%
Active trend streak0 weeks
Active weeks in one year32
Trend breadth61.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.58Latest activity-pressure read.
Pressure change213.3%Four-week change in activity pressure.
Leadership-13.81Latest relative-leadership reading.
RS change-55.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength5/100Blend of value, momentum, and quality. Underlying universe rank 96; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality30/100Profitability and accounting quality. Underlying universe rank 71; rank 1 is best.
Momentum33/100Medium-term price momentum. Underlying universe rank 68; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
5.3x
Market value relative to trailing revenue.
EV / EBITDA
52.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
74.1%
Gross profit retained from each unit of revenue.
Operating margin
4.5%
Operating profit retained from revenue.
Free-cash-flow margin
6.0%
Free cash flow generated from revenue.
Return on invested capital
3.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
26.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-60.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
6.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

HROW shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.41, expected move of 17.6%, and Sharemaestro trend signal inactive.

Conviction37/100
Expected move17.6%
Put/call volume0.41
Pressure52
Speculation17
Volatility96
Trend agreement6
Open options detail
Insider activity8 / 0

8 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment57/100

Weighted news tone is neutral across 52 relevant articles.

21 positive · 24 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move17.6%Nearest-chain priced movement where available.
52-week drawdown-29.9%Distance below the 52-week high.
13-week volatility9.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+15.6%Week of 6 Feb.
Worst week-32.9%Week of 6 Mar.
Latest week-17.6%Week of 24 Jul.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses3
Sharp losses8
Recent vol9.9%13-week weekly-return volatility.
Base vol9.8%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -7.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape34/100

Trend, activity pressure, participation, and risk combine to a 34/100 tape read.

 Indicator analysis23/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 1/12.

Activity pressure 0.21; No reversal markers Factors16/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 57; Small Cap Core rank 98 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options42/100

HROW shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.41, expected move of 17.6%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 17.6% Sentiment57/100

Weighted news tone is neutral across 52 relevant articles.

BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63 Insiders8 / 0

8 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings11d

Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202638.45 USD-17.6%40.86 USD29.87 USD0.58-13.813.2MOff
17 Jul 202646.65 USD9.8%41.25 USD29.76 USD0.782.662.9MOff
10 Jul 202642.48 USD-0.6%41.24 USD29.60 USD0.73-10.333.2MOff
3 Jul 202642.74 USD1.6%41.39 USD29.44 USD0.63-8.272.7MOff
26 Jun 202642.07 USD-1.9%41.49 USD29.29 USD0.18-8.865.1MOff
19 Jun 202642.87 USD13.9%41.48 USD29.14 USD-0.25-11.233.3MOff
12 Jun 202637.64 USD13.4%41.35 USD28.98 USD-0.64-19.994.5MOff
5 Jun 202633.19 USD-5.7%41.46 USD28.86 USD-0.86-27.943.1MOff
29 May 202635.21 USD6.7%41.48 USD28.78 USD-0.70-27.193.3MOff
22 May 202633.00 USD5.7%41.57 USD28.68 USD-0.60-29.924.0MOff
15 May 202631.21 USD-18.4%41.75 USD28.60 USD-0.55-33.0111.1MOff
8 May 202638.23 USD-6.5%42.04 USD28.53 USD-0.56-18.472.5MOff
1 May 202640.90 USD3.0%42.02 USD28.43 USD-0.73-7.882.5MOff
24 Apr 202639.70 USD-4.3%42.17 USD28.34 USD-0.95-8.992.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.